Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Anticoagulant-induced Bleeding
- Bleeding
- Cardiovascular Diseases
- Embolism
- Embolism and Thrombosis
- Lung Diseases
- Pulmonary Embolism
- Respiratory Tract Diseases
- Venous Thromboembolism
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04263038
- Collaborators
- University of Bern
- Schweizerischer Nationalfonds
- Leiden University Medical Center
- The Ottawa Hospital
- Bayer
- Investigators
- Study Director: Drahomir Aujesky, Prof. MD MSc Inselspital, Bern University Hospital, University of Bern